May 6, 2026 08:31AM
May 4, 2026 08:30AM
Mar 27, 2026 06:46AM
Mar 12, 2026 08:03AM
Feb 11, 2026 08:31AM
Feb 5, 2026 08:31AM
Jan 6, 2026 08:15AM Atossa Therapeutics gets FDA clearance for breast cancer drug study
Dec 11, 2025 08:02AM
Dec 9, 2025 08:01AM
Dec 8, 2025 04:46AM
Dec 5, 2025 06:46AM
Dec 4, 2025 08:01AM
Dec 2, 2025 08:01AM
Nov 17, 2025 09:09AM Atossa highlights potential for endoxifen in muscular dystrophy treatment
Nov 12, 2025 04:23PM
Oct 14, 2025 07:53AM
Oct 7, 2025 06:47AM
Oct 6, 2025 08:04AM
Oct 1, 2025 08:32AM
Sep 9, 2025 06:52AM
Sep 8, 2025 08:30AM Atossa requests FDA meeting for endoxifen breast cancer drug development
Aug 29, 2025 09:00AM
Aug 12, 2025 09:46AM
Aug 1, 2025 09:00AM
Jun 6, 2025 05:21AM
Jun 5, 2025 08:39AM
May 20, 2025 09:00AM
May 13, 2025 05:31PM Atossa Genetics (ATOS) Tops Q1 EPS by 2c
May 2, 2025 09:00AM
Apr 30, 2025 08:45AM
Apr 29, 2025 08:47AM
Apr 22, 2025 08:45AM
Mar 26, 2025 06:52AM
Mar 11, 2025 08:15AM
Jan 30, 2025 08:17AM Atossa Therapeutics (ATOS) Responds to PTAB Ruling on U.S. Patent No. 11,572,334 and Announces the Issuance of U.S. Patent No. 12,201,591
Jan 23, 2025 08:15AM
Dec 11, 2024 08:15AM
Nov 13, 2024 06:54AM
Nov 5, 2024 08:05AM
Nov 4, 2024 06:30AM
Oct 31, 2024 08:15AM
Sep 10, 2024 08:30AM Atossa Therapeutics (ATOS) Announces Support of Final Rule from FDA Requiring Patient Notification of Breast Density, a Critical Step in Addressing a Known Risk Factor for Breast Cancer
Aug 28, 2024 08:31AM
Aug 21, 2024 11:37AM
Aug 21, 2024 08:37AM
Aug 12, 2024 05:06PM
Jul 2, 2024 04:15PM
Jul 1, 2024 06:43AM
Jun 28, 2024 08:32AM Atossa Therapeutics (ATOS) Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combination with Abemaciclib in Women with ER+/HER2- Breast Cancer

401,066 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All